803 related articles for article (PubMed ID: 26208975)
1. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
2. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis.
Kalli M; Mpekris F; Wong CK; Panagi M; Ozturk S; Thiagalingam S; Stylianopoulos T; Papageorgis P
Front Oncol; 2019; 9():32. PubMed ID: 30805303
[TBL] [Abstract][Full Text] [Related]
3. IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.
Xie M; Wu XJ; Zhang JJ; He CS
Oncotarget; 2015 Oct; 6(32):32902-13. PubMed ID: 26418721
[TBL] [Abstract][Full Text] [Related]
4. Nuclear translocation of PLSCR1 activates STAT1 signaling in basal-like breast cancer.
Huang P; Liao R; Chen X; Wu X; Li X; Wang Y; Cao Q; Dong C
Theranostics; 2020; 10(10):4644-4658. PubMed ID: 32292520
[No Abstract] [Full Text] [Related]
5. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.
Bartolomé RA; Jaén M; Casal JI
Br J Cancer; 2018 Oct; 119(8):940-949. PubMed ID: 30318506
[TBL] [Abstract][Full Text] [Related]
6. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
7. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of metastasis-associated genes identifies miR-17-5p as a metastatic suppressor of basal-like breast cancer.
Fan M; Sethuraman A; Brown M; Sun W; Pfeffer LM
Breast Cancer Res Treat; 2014 Aug; 146(3):487-502. PubMed ID: 25001613
[TBL] [Abstract][Full Text] [Related]
9. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
10. Genomic pathways modulated by Twist in breast cancer.
Vesuna F; Bergman Y; Raman V
BMC Cancer; 2017 Jan; 17(1):52. PubMed ID: 28086829
[TBL] [Abstract][Full Text] [Related]
11. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
12. A novel target anti-interleukin-13 receptor subunit alpha-2 monoclonal antibody inhibits tumor growth and metastasis in lung cancer.
Raza G; Yunus FU; Mangukiya HB; Merugu SB; Mashausi DS; Zeling W; Negi H; Zhou B; Roy D; Wu Z; Li D
Int Immunopharmacol; 2021 Jan; 90():107155. PubMed ID: 33243603
[TBL] [Abstract][Full Text] [Related]
13. Genes that mediate breast cancer metastasis to lung.
Minn AJ; Gupta GP; Siegel PM; Bos PD; Shu W; Giri DD; Viale A; Olshen AB; Gerald WL; Massagué J
Nature; 2005 Jul; 436(7050):518-24. PubMed ID: 16049480
[TBL] [Abstract][Full Text] [Related]
14. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
15. GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.
Maric G; Annis MG; Dong Z; Rose AA; Ng S; Perkins D; MacDonald PA; Ouellet V; Russo C; Siegel PM
Oncogene; 2015 Oct; 34(43):5494-504. PubMed ID: 25772243
[TBL] [Abstract][Full Text] [Related]
16. LincIN, a novel NF90-binding long non-coding RNA, is overexpressed in advanced breast tumors and involved in metastasis.
Jiang Z; Slater CM; Zhou Y; Devarajan K; Ruth KJ; Li Y; Cai KQ; Daly M; Chen X
Breast Cancer Res; 2017 May; 19(1):62. PubMed ID: 28558830
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer.
Jaén M; Martín-Regalado Á; Bartolomé RA; Robles J; Casal JI
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188802. PubMed ID: 36152905
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 receptor alpha2 is a novel therapeutic target for human adrenocortical carcinoma.
Jain M; Zhang L; He M; Patterson EE; Nilubol N; Fojo AT; Joshi B; Puri R; Kebebew E
Cancer; 2012 Nov; 118(22):5698-708. PubMed ID: 22570059
[TBL] [Abstract][Full Text] [Related]
19. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaPM cells.
He H; Xu J; Nelson PS; Marshall FF; Chung LW; Zhau HE; He D; Wang R
Prostate; 2010 Jun; 70(9):993-1001. PubMed ID: 20166133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
